Cytokinetics | CYTK - Stock


Cytokinetics reported $154K in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 31.57M 3.1M Mar/2026
Amgen USD 6.19B 39M Mar/2026
Bayer EUR 12.34B 3M Dec/2025
Biogen USD 1.95B 219.1M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 14.53B 785M Mar/2026
Exelixis USD 26.6M 4.92M Mar/2026
Geron USD 133.29M 16.65M Mar/2026
Halozyme Therapeutics USD 155.47M 21.01M Mar/2026
Ionis Pharmaceuticals USD 5.56M 4.49M Mar/2026
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
Merck USD 6.48B 179M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025